氯诺昔康用于腹腔镜卵巢肿瘤切除术后镇痛的临床观察  

Postoperative analgesic effects of lornoxicam in patients undergoing laparoscopic surgery of the ovarian tumor

作　　者：许睿[1] 张凤[1] 张庆国[1] 曾繁荣[1] 徐世元[1] 

机构地区：[1]南方医科大学珠江医院麻醉科,广州510282

出　　处：《中国新药杂志》2005年第10期1216-1218,共3页Chinese Journal of New Drugs

摘　　要：目的:评价氯诺昔康持续静脉镇痛用于腹腔镜卵巢肿瘤切除术后的临床效果。方法:择期行腹腔镜卵巢切除术的患者60例,随机平均分为氯诺昔康组和对照组两组。氯诺昔康组(n=30)应用PCA镇痛(每次1 mL,总量40 mg/48 h),并于手术结束前半小时静脉注射氯诺昔康8 mg。术后行疼痛评分(BCS)及不良反应的观察。对照组(n=30)为空白对照。结果:氯诺昔康组术后BCS评分显著高于对照组。两组的不良反应发生率无显著性差异。结论:腹腔镜卵巢肿瘤切除术后应用氯诺昔康静脉持续镇痛,效果确切,不良反应少。Objective：To assess the analgesic effects of lomoxicam in patients undergoing laparoscopic surgery of the ovarian tumor. Methods： 60 patients undergoing elective laparoscopic surgery of the ovarian tumor were randomly 1 ： 1 assigned to one of two groups： treatment group received postoperative controlled analgesia plus intravenous injection of lomoxicam 8 mg 30 minutes ahead of the operative closure or a blank control group without lornoxicam. The efficacy was evaluated based on pain scores （BCS）. Results： A statistical difference of pain scores （BCS） was found between lomoxicam and blank group. No significant difference of safety profiles between lomoxicam and blank group was observed. Conclusion： Postoperative pain relief with lomoxicam for laparoscopic surgery of ovarian tumors was achieved.

关 键 词：氯诺昔康 镇痛 腹腔镜手术 

分 类 号：R969.4[医药卫生—药理学] R071.1[医药卫生—药学]